Aerosol Inhalation Treatment for Dyspnea



Status:Active, not recruiting
Conditions:Healthy Studies, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:3/8/2017
Start Date:September 2011
End Date:August 2017

Use our guide to learn which trials are right for you!

The purpose of this protocol is to develop and test optimal delivery of aerosol furosemide,
a treatment that has the potential to significantly improve symptom management and enhance
the quality of care for patients with intractable dyspnea.

This is study of aerosol treatment in a laboratory model of dyspnea in healthy subjects.
This study is the first in a series of studies that will include investigation of a second
dose in the laboratory and investigation of the treatment effect in hospitalized patients
with refractory dyspnea. The outcome of this first study will determine the details of
protocol for the succeeding studies.

Inclusion Criteria:

- Healthy

Exclusion Criteria:

- Unstable heart or circulation disease

- Stroke

- Seizure disorder

- Severe migraine headaches

- Liver or kidney disease

- Adrenal gland problem (Pheochromocytoma)

- Nerve problems that may affect your breathing sensation

- Brain cancer

- Drug or alcohol problem

- Systemic lupus erythematosis (SLE)

- High levels of depression, panic disorder, or other significant mental health
problems

- Serious ongoing pain

- Pregnant

- Under 18 years old

- Not Fluent in English
We found this trial at
1
site
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials